348 related articles for article (PubMed ID: 26866895)
1. Role of Molecular Interactions for Synergistic Precipitation Inhibition of Poorly Soluble Drug in Supersaturated Drug-Polymer-Polymer Ternary Solution.
Prasad D; Chauhan H; Atef E
Mol Pharm; 2016 Mar; 13(3):756-65. PubMed ID: 26866895
[TBL] [Abstract][Full Text] [Related]
2. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.
Prasad D; Chauhan H; Atef E
J Pharm Sci; 2014 Nov; 103(11):3511-3523. PubMed ID: 25196860
[TBL] [Abstract][Full Text] [Related]
3. Correlation of inhibitory effects of polymers on indomethacin precipitation in solution and amorphous solid crystallization based on molecular interaction.
Chauhan H; Kuldipkumar A; Barder T; Medek A; Gu CH; Atef E
Pharm Res; 2014 Feb; 31(2):500-15. PubMed ID: 24122167
[TBL] [Abstract][Full Text] [Related]
4. Polymer incorporation method affects the physical stability of amorphous indomethacin in aqueous suspension.
Surwase SA; Itkonen L; Aaltonen J; Saville D; Rades T; Peltonen L; Strachan CJ
Eur J Pharm Biopharm; 2015 Oct; 96():32-43. PubMed ID: 26092472
[TBL] [Abstract][Full Text] [Related]
5. Correlating the behavior of polymers in solution as precipitation inhibitor to its amorphous stabilization ability in solid dispersions.
Chauhan H; Hui-Gu C; Atef E
J Pharm Sci; 2013 Jun; 102(6):1924-1935. PubMed ID: 23580406
[TBL] [Abstract][Full Text] [Related]
6. Drug-polymer miscibility, interactions, and precipitation inhibition studies for the development of amorphous solid dispersions for the poorly soluble anticancer drug flutamide.
Trivino A; Gumireddy A; Meng F; Prasad D; Chauhan H
Drug Dev Ind Pharm; 2019 Aug; 45(8):1277-1291. PubMed ID: 31111732
[TBL] [Abstract][Full Text] [Related]
7. Influence of PVP molecular weight on the microwave assisted in situ amorphization of indomethacin.
Doreth M; Löbmann K; Priemel P; Grohganz H; Taylor R; Holm R; Lopez de Diego H; Rades T
Eur J Pharm Biopharm; 2018 Jan; 122():62-69. PubMed ID: 28986296
[TBL] [Abstract][Full Text] [Related]
8. Characterization of physico-mechanical properties of indomethacin and polymers to assess their suitability for hot-melt extrusion processs as a means to manufacture solid dispersion/solution.
Chokshi RJ; Sandhu HK; Iyer RM; Shah NH; Malick AW; Zia H
J Pharm Sci; 2005 Nov; 94(11):2463-74. PubMed ID: 16200544
[TBL] [Abstract][Full Text] [Related]
9. Phase Behavior of Resveratrol Solid Dispersions Upon Addition to Aqueous media.
Wegiel LA; Mosquera-Giraldo LI; Mauer LJ; Edgar KJ; Taylor LS
Pharm Res; 2015 Oct; 32(10):3324-37. PubMed ID: 25975588
[TBL] [Abstract][Full Text] [Related]
10. Molecular structure and impact of amorphization strategies on intrinsic dissolution of spray dried indomethacin.
Li Y; Rantanen J; Yang M; Bohr A
Eur J Pharm Sci; 2019 Mar; 129():1-9. PubMed ID: 30553059
[TBL] [Abstract][Full Text] [Related]
11. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers.
Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
J Pharm Sci; 2013 Jan; 102(1):171-84. PubMed ID: 23132686
[TBL] [Abstract][Full Text] [Related]
12. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
Sun DD; Ju TC; Lee PI
Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
[TBL] [Abstract][Full Text] [Related]
13. Dissolution enhancement of the anti-HIV drug UC 781 by formulation in a ternary solid dispersion with TPGS 1000 and Eudragit E100.
Goddeeris C; Willems T; Houthoofd K; Martens JA; Van den Mooter G
Eur J Pharm Biopharm; 2008 Nov; 70(3):861-8. PubMed ID: 18691650
[TBL] [Abstract][Full Text] [Related]
14. Impacts of Polymeric Additives on Nucleation and Crystal Growth of Indomethacin from Supersaturated Solutions.
Cheng H; Mao L; Zhang S; Lv H
AAPS PharmSciTech; 2019 May; 20(5):193. PubMed ID: 31115746
[TBL] [Abstract][Full Text] [Related]
15. A method to predict the equilibrium solubility of drugs in solid polymers near room temperature using thermal analysis.
Bellantone RA; Patel P; Sandhu H; Choi DS; Singhal D; Chokshi H; Malick AW; Shah N
J Pharm Sci; 2012 Dec; 101(12):4549-58. PubMed ID: 22987330
[TBL] [Abstract][Full Text] [Related]
16. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
Fini A; Cavallari C; Ospitali F
Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
[TBL] [Abstract][Full Text] [Related]
17. Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration.
Chokshi RJ; Shah NH; Sandhu HK; Malick AW; Zia H
J Pharm Sci; 2008 Jun; 97(6):2286-98. PubMed ID: 17879977
[TBL] [Abstract][Full Text] [Related]
18. Solubilities of crystalline drugs in polymers: an improved analytical method and comparison of solubilities of indomethacin and nifedipine in PVP, PVP/VA, and PVAc.
Sun Y; Tao J; Zhang GG; Yu L
J Pharm Sci; 2010 Sep; 99(9):4023-31. PubMed ID: 20607809
[TBL] [Abstract][Full Text] [Related]
19. Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers.
Sun DD; Lee PI
J Control Release; 2015 Aug; 211():85-93. PubMed ID: 26054795
[TBL] [Abstract][Full Text] [Related]
20. Identification of molecular-interaction sites between lowly hydrolyzed polyvinyl alcohols and indomethacin by NMR spectroscopy.
Mori Y; Takahashi M; Ohno Y; Okura R; Ishida M; Higashi T; Motoyama K; Arima H
Int J Pharm; 2018 Oct; 549(1-2):456-465. PubMed ID: 30110620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
